Aura Biosciences, Inc. (AURA)
NASDAQ·Healthcare·Biotechnology
$6.96
+0.00%
Mkt Cap $466.37M
EPS — Estimate vs Actual
Revenue — Estimate vs Actual
Quarterly History
| Q1 2026 Mar 30, 2026 | — | — | — | -$0.43 | -$0.37 | +13.95% | — | — |
| Q4 2025 Nov 13, 2025 | — | — | — | -$0.46 | -$0.40 | +13.04% | — | — |
| Q3 2025 Aug 13, 2025 | — | — | — | -$0.49 | -$0.47 | +4.08% | — | — |
| Q2 2025 May 15, 2025 | — | — | — | -$0.47 | -$0.55 | -17.02% | — | — |
| Q1 2025 Mar 24, 2025 | — | — | — | -$0.43 | -$0.52 | -20.93% | — | — |
| Q4 2024 Nov 12, 2024 | — | — | — | -$0.44 | -$0.42 | +4.55% | — | — |
| Q3 2024 Aug 8, 2024 | — | — | — | -$0.45 | -$0.41 | +8.89% | — | — |
| Q2 2024 May 9, 2024 | — | — | — | -$0.51 | -$0.40 | +21.57% | — | — |
| Q1 2024 Mar 27, 2024 | — | $2.06M | — | -$0.39 | -$0.50 | -28.21% | — | — |
| Q4 2023 Nov 9, 2023 | — | — | — | -$0.54 | -$0.48 | +11.11% | — | — |
| Q3 2023 Aug 9, 2023 | — | — | — | -$0.49 | -$0.48 | +2.04% | — | — |
| Q2 2023 May 11, 2023 | — | — | — | -$0.52 | -$0.46 | +11.54% | — | — |
| Q1 2023 Mar 15, 2023 | — | — | — | -$0.58 | -$0.52 | +10.34% | — | — |
| Q4 2022 Nov 10, 2022 | — | — | — | -$0.52 | -$0.53 | -1.92% | — | — |
| Q3 2022 Aug 11, 2022 | — | — | — | -$0.48 | -$0.46 | +4.17% | — | — |
| Q2 2022 May 12, 2022 | — | — | — | -$0.44 | -$0.44 | +0.00% | — | — |
| Q1 2022 Mar 23, 2022 | — | — | — | -$0.39 | -$2.51 | -543.59% | — | — |
| Q4 2021 Nov 24, 2021 | — | — | — | — | -$0.32 | — | — | — |
| Q4 2021 Nov 1, 2021 | — | — | — | — | -$0.45 | — | — | — |
| Q1 2021 Mar 31, 2021 | — | — | — | — | -$0.30 | — | — | — |